Theragene Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Gene Therapies For Rare Diseases market is expected to reach US$ 11,441.6 Million by 2030, with a CAGR of 21.7% during a forecast period of 2022-2030.

United statesKrasnoyarskiy kraySouth africaNew zealandSouth koreaVolgogradskaya oblastMiltenyi biotecNeurotherapeuticsy bioAngelini pharmaTheragene pharmaOxford biomedicaTalee bioAsia pacificApic bioDaewoong pharmaGenetic technologies corporation